Press Releases
Tjoapack receives investment from Ampersand Capital Partners
Tjoapack Netherlands B.V., a global contract packaging organisation (CPO) for the pharmaceutical industry, announced a majority investment from Ampersand Capital Partners, a private equity firm that specialises in partnering with entrepreneur-led healthcare companies. Ampersand’s investment will be used to...
IT & Data Management
InterSystems Partner WellSky International Provides Digital Support Services to the NHS During the COVID-19 outbreak
WellSky International Ltd, providers of medicine management solutions (Pharmacy, EPMA and Chemotherapy) to the United Kingdom’s National Health Service (NHS), has sought to take a proactive role in supporting the NHS during the COVID-19 pandemic.
In the spirit of the...
Press Releases
Sense Accelerates Instrument-Free Molecular Diagnostic Test for COVID-19
Sense Biodetection Limited (Sense) has announced an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
Sense is partnering closely with Phillips-Medisize, a Molex company and leading global...
Drug Research
NovelStem Announces Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and COVID-19 Resistance
NovelStem International Corp. , a biotechnology company focused on its stem cell-based technology platform, developed by Israel-based affiliate, NewStem Ltd., announced two new collaborations to apply NewStem’s technology platform, one to research a potential cancer immunotherapy drug and another...
Press Releases
INTERPHEX Creates Launch Year-Round Online Resource, RECONNEX 365
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical, biotechnology and device innovation, technology and knowledge from development through commercialization, is pleased to launch RECONNEX 365. At RECONNEX 365, visitors have access to year-round online resource of pharma,...
Drug Research
AdaptVac teams up with AGC Biologics to develop and produce COVID-19 vaccine
AGC Biologics , a leading provider of biopharmaceutical contract development and manufacturing organization (CDMO), announced its partnership with AdaptVac. The partnership was formed to jointly develop and manufacture a COVID-19 vaccine. AdaptVac is developing a SARS-CoV-2 vaccine together with...
Packaging & Labelling
Catalent Biologics Completes $14 Million Commercial Packaging Expansion at its Bloomington, Indiana Facility
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced the completion of its $14 million expansion to increase the biologics packaging capabilities and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.